J Hauptman

Summary

Affiliation: F. Hoffmann-La Roche Ltd

Publications

  1. ncbi Orlistat in the long-term treatment of obesity in primary care settings
    J Hauptman
    Department of International Clinical Research, Hoffman LaRoche Inc, Nutley, NJ 07110, USA
    Arch Fam Med 9:160-7. 2000
  2. ncbi Orlistat: selective inhibition of caloric absorption can affect long-term body weight
    J Hauptman
    Hoffmann La Roche Inc, Nutley, NJ 07110 1199, USA
    Endocrine 13:201-6. 2000

Collaborators

Detail Information

Publications2

  1. ncbi Orlistat in the long-term treatment of obesity in primary care settings
    J Hauptman
    Department of International Clinical Research, Hoffman LaRoche Inc, Nutley, NJ 07110, USA
    Arch Fam Med 9:160-7. 2000
    ..To evaluate the long-term efficacy and tolerability within primary care settings of orlistat, a gastrointestinal lipase inhibitor, for the treatment of obesity...
  2. ncbi Orlistat: selective inhibition of caloric absorption can affect long-term body weight
    J Hauptman
    Hoffmann La Roche Inc, Nutley, NJ 07110 1199, USA
    Endocrine 13:201-6. 2000
    ..Orlistat acts locally in the gastrointestinal tract and is only minimally absorbed. In long-term clinical trials, orlistat was well tolerated by both diabetic and nondiabetic subjects...